Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
6,7-dimethoxy-4-[(3R)-3-(2-naphthyloxy)pyrrolidin-1-yl]quinazoline
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C24H23N3O3 and a molecular weight of approximately 401.46 g/mol. It is listed in DrugBank as DB08389 and classified as an experimental drug with no approved medical indications or established mechanism of action. The structure features a quinazoline core substituted at the 4-position by a (3R)-3-(2-naphthyloxy)pyrrolidinyl group and methoxy groups at positions 6 and 7. There is no available information on its pharmacological activity, clinical development status, or therapeutic use[1][6].
- Other names
- 6,7-dimethoxy-4-[(3R)-3-(2-naphthyloxy)pyrrolidin-1-yl]quinazolineDB08389DB-08389DB 083896,7-dimethoxy-4-(naphthalen-2-yloxy)pyrrolidinyl)quinazoline (IUPAC)
02
Targets
PDE3B (Phosphodiesterase 3B)PDE3A (Phosphodiesterase 3A)PDE10A (Phosphodiesterase 10A)
Beyond the preview
Go deeper on 6,7-dimethoxy-4-[(3R)-3-(2-naphthyloxy)pyrrolidin-1-yl]quinazoline.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 6,7-dimethoxy-4-[(3R)-3-(2-naphthyloxy)pyrrolidin-1-yl]quinazoline.